CIDRAP newsletters options
As daily cases stay above 300,000, scores of bodies turn up in some of India's rivers.
Compared with non-pregnant women hospitalized with COVID-19, pregnant women with COVID-19 had lower in-hospital death rates, according to a research letter in the Annals of Internal Medicine today.
CARB-X announced today that it is awarding Australian diagnostics company SpeeDx up to $1.8 million to develop a rapid molecular diagnostic test for chlamydia and gonorrhea infections.
The CDC says 44% of US adults are now fully vaccinated, as are 72% of seniors.
"We now have clear evidence that NSAIDs are safe to use in patients with COVID-19."
Also, India is reporting an increase in potentially deadly fungal lung infections.
Mild COVID-19 infection was not linked to longer-term heart damage, according to a JACC Cardiovascular Imaging study late last week.
Use of infectious diseases (ID) telemedicine for management of Staphylococcus aureus bacteremia (SAB) at 10 US hospitals resulted in similar outcomes compared with on-site consultation, researchers reported today in Open Forum Infectious Diseases.
Also, India reports another daily record for deaths—4,197—along with 401,271 new cases.
While states are becoming optimistic, experts continue to advocate for aerosol-related mitigations.
Israeli data show 92% effectiveness against asymptomatic COVID and 97% against symptomatic.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Direct COVID-19 deaths may be more than double previous estimates, according to a report yesterday by the University of Washington's Institute for Health Metrics and Evaluation (IHME).
Data from a cohort of US acute care hospitals (ACHs) reveal an association between total and broad-spectrum antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) rates, researchers from the Centers for Disease Control and Prevention (CDC) reported today in Infection Control & Hospital Epidemiology.
Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.
The vaccines show either effectiveness or a strong immune response against variants of concern.
Also, mixed reactions swirled on the proposed IP vaccine waiver, and more Asian nations took steps to battle COVID-19.
Modeling from the CDC predicts the US will see a sharp drop in infections and deaths in the coming weeks.
Saudi Arabia's Ministry of Health (MOH) today reported a new MERS-CoV case, which involves a 36-year-old man who died from his infection.
The man was from Hafr Al-Batin in the country's northeast. An investigation found that the man had been exposed to camels. He wasn't a healthcare worker and isn't thought to have contracted MERS-CoV (Middle East respiratory syndrome coronavirus) from another person.
The AstraZeneca-Oxford COVID-19 vaccine is associated with some increases in bleeding and clotting events, according to a BMJ study yesterday, but experts say the benefits outweigh the risks.
